AI Maverick Intel (OTCID: AIMV) announced that it has entered into a definitive share purchase agreement to acquire Heal Access Canada Inc., an artificial intelligence (“AI”) healthcare technology company, from its controlling stockholder, HEAL Group Holdings Inc. The transaction includes $5 million in consideration through a secured, two-year promissory note bearing 10% annual interest, plus 20 million exchangeable shares convertible into AIMV common stock. Heal Access operates an AI-powered healthcare intelligence platform that integrates patient information and supports clinical workflows. The platform is operational in five countries and serves more than 118,000 patients. The acquisition remains subject to several closing conditions, including at least $6 million in financing and independent special committee ratification.
AIMV expects to use commercially reasonable efforts to complete the required financing by Dec. 31, 2026, with either party permitted to terminate the agreement if the transaction has not closed by Feb. 28, 2027. The company will also assume approximately $6.4 million in existing obligations owed by Heal Access and its subsidiaries to HEAL Group and affiliates. AIMV clarified that its Sept. 21 announcement incorrectly described the acquisition agreement as definitive, noting that the binding agreement was signed Oct. 12, 2026. Upon conversion of all exchangeable shares, HEAL Group would hold approximately 80.1% of AIMV common stock before accounting for any shares issued in the financing.
To view the full press release, visit https://ibn.fm/xlVAo
About AI Maverick Intel, Inc.
AI Maverick Intel, Inc. is a Delaware corporation focused on artificial intelligence in healthcare. AIMV has agreed to acquire Heal Access, an agentic AI healthcare platform live in five countries, and intends to grow through Heal Access and through further acquisitions of AI and technology-enabled healthcare businesses, including opportunities available to it under its right of first refusal agreement with HEAL Group Holdings Inc., its controlling stockholder. AIMV’s common stock is quoted on the OTCID Basic Market operated by OTC Markets Group Inc. under the symbol “AIMV”.
NOTE TO INVESTORS: The latest news and updates relating to AIMV are available in the company’s newsroom at http://ibn.fm/AIMV
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]
InvestorWire is powered by IBN